|
'Speeches'
Alexandra Wyke, speech, "Utilising patient compliance strategies for clinical trials", 3rd Annual Forum on Patient Adherence, Compliance and Persistency: Increase Product Utilisation through Improved Patient Communication Strategies, Holiday Inn, Chaussee de Charleroi, Brussels, Belgium, Tuesday October 24 2006.
Alexandra Wyke, speech, "Understanding patient communication regulation across Europe: what can pharma companies do in terms of patient communication?" , 3rd Annual Patient Compliance Conference Europe, Amsterdam Marriott Hotel, Amsterdam, the Netherlands, Thursday June 1 2006.
Alexandra Wyke, "Patient perceptions of electronic medical records: a global survey", speech, World Health Care Innovation and Technology Congress: 'Innovation to Transform', Marriott Wardman Park Hotel, Washington DC, USA, Wednesday November 9 2005.
Alexandra Wyke, "New models for engaging patients: usurping public-private partnerships (PPPs)", speech, Center for Business Intelligence's 2nd Annual Patient Compliance, Persistency and Disease Management Conference, Radisson Hotel, Amsterdam, the Netherlands, Monday September 19 2005.
http://www.cbinet.com/show_conference.cfm?confCode=HB564&field=dayone
Alexandra
Wyke, Congress Advisory Board, European Health Care Congress: Best practices
for improved delivery and solutions, Les Fontaines Conference Centre,
Paris, France, Monday April 11 - Tuesday April 12 2005.
http://www.worldcongress.com/europe/advisory_board.cfm
Alexandra
Wyke, chair, "Patients' Rights in Europe: A Citizens' Report-Monitoring
the European Charter of Patients' Rights", Active Citizenship
Network (ACN), Paul Henry Spaak Building, European Parliament, Brussels,
Belgium, Monday, February 28 2005.
http://www.activecitizenship.net/home.html
Alexandra
Wyke, "Cancer patients and their rights to information in the
EU", speech, 1st Summit of Cancer Patients Advocacy Groups
in Central and Eastern Europe: 'Can Patients Cure a Healthcare System?',
Sofitel Victoria Hotel, Warsaw, Poland, Saturday, November 27 2004.
Alexandra
Wyke, "Engaging the family in healthcare: Using e-technologies
to interact with patients and the public (the results of a global survey
by Health and Social Campaigners' Network, September 2004)",
speech, eHealth 2004 Clinical Information Systems and Electronic Records
Conference, London West Convention Centre, London, UK, Thursday, September
30 2004.
http://www.healthcare-events.co.uk/conferences/confdisplay.asp?id=262
Alexandra
Wyke,"Spreading the word: how health campaigners can disseminate
key ideas to a wider audience", speech, Mental Health Europe
European Seminar: 'Harassment and Discrimination Faced by People with
a Pychosocial Disability in Health Services', Brussels, Belgium, April
23 2004.
Alexandra
Wyke, "What drug information do patients want? UK and European
issues", speech, Centre for Health Information Quality
Conference: 'Better Information, Better Communication in Healthcare',
London, UK, February 4 2004.
Alexandra
Wyke, "The patient's view and ethical considerations of medical technology",
speech, International Workshop: 'New Generation of Wearable Systems
for Health', University of Pisa, Italy, December 13 2003.
Alexandra
Wyke, "Patient information on prescription medicine: a
global perspective", Barcelona, Spai
n, June 27 2003.
Alexandra
Wyke, "Summary of the meeting", speech, Health Coalition
Initiative/Long term Medical Conditions Alliance/Gamian Europe/PatientView/IBM
Workshop
Seminar: 'Patient Information, European Directives - the Meaning
for UK Patients and Patient Groups', London, UK, May 12 2003.
Alexandra
Wyke, "Why do patients want more prescription information?",
speech, 5th Annual Direct-to-Consumer Pharmaceutical Marketing and Communication
Forum, Warwickshire, UK, April 3 2003.
Alexandra
Wyke, panel member, "Healthcare systems of the future", 2nd
Global Medical Forum, Zurich, Switzerland, March 24 2003.
Alexandra
Wyke, "Patient perspective on information", speech, Journalists'
Seminar, The Vienna Educational Symposium on Cancer Anaemia Management,
Vienna, Austria, March 20 2003. Alexandra
Wyke, "The priorities for patients in Europe", speech, 15th Annual
Drug Information Association (DIA) EuroMeeting, Rome, Italy, March 7
2003.
Alexandra
Wyke, "Should pharmaceutical companies supply the public with more
prescription drug information? The views of EU-based patient groups",
speech, The Future Patient Conference, Brussels, Belgium, November 15
2002.
Alexandra
Wyke, "Should pharmaceutical companies supply the public with more
prescription drug information? The views of EU-based patient groups",
speech, Journalists' Seminar, Brussels, Belgium, October 10 2002.
Alexandra
Wyke, "Should pharmaceutical companies supply the public with more
prescription drug information?", speech, e-healthcare conference,
Zurich, Switzerland, October 4 2002.
Alexandra
Wyke, "Understanding the effects of direct-to-consumer prescription
drug advertising", speech, 21st International Federation of Pharmaceutical
Manufacturers Associations (IFPMA) Assembly, Berlin, Germany, October
1 2002.
Alexandra
Wyke, "Should pharmaceutical companies supply the public with
more prescription drug information? The views of EU-based patient
groups - a
collaborative project between IAPO and PatientView", speech, Special
Session, European Health Forum Gastein, Bad Hofgastein, Austria, September
26 2002.
Alexandra
Wyke, "Should direct-to-consumer prescription drug advertising be
allowed?", speech, 5th Pharmacological Conference, Foundation for
Scientific Culture, Erice, Sicily, May 12 2002.
Alexandra
Wyke, "The e-health consumer and the pharmaceutical industry",
speech, e-healthcare consumer forum, INSEAD, Fontainebleau, France,
June 9 2000.
http://www.insead.fr/events/e-health/presentations.htm
back
to top
'Coverage
on PatientView'
√ Few patient groups admit links to drug companies
Financial Times, Monday May 1 2006, page 3
Article by Andrew Jack
"Patients' groups are growing in strength and influence but remain opaque about whether they receive funding from drug companies, according to a pioneering analysis of their financial disclosures. Only 11 per cent of the UK's 530 largest patients' groups state publicly that they receive support from the pharmaceutical industry, a study by PatientView, the market research and publishing house has revealed. ... The new study found that just 10 groups stated the percentage of income they received from drug companies. ... The research comes on the day a new code of conduct comes into effect for members of the Association of British Pharmaceutical Industry. ...Despite this, the PatientView study suggests that the patients' groups receiving funding remain opaque in disclosing the levels of corporate support."
√ Cancerworld website
HSCNews article about clinical trials, with an interview given by ECPC, October 2005.
On European Cancer Patient Coalition page / Advocacy page / Clinical Trials page
Reference to 'Clinical trials registration', HSCNews International , issue 22, October 2005.
http://www.cancerworld.org/cancerworldadmin/getStaticModFile.aspx?id=872
√ The United Kingdom Parliament, Select Committee on Health, Written Evidence, Annex C
April 26th 2005
'The management of the newly created MHRA were aware of the changing context of their work and the need to ensure that public health messages were received by stakeholders. Accordingly, in December 2003, the Agency commissioned a major study of its external profile involving 27 external stakeholder interviews, an online survey of health and social campaigners and an internal consultation programme.'
http://www.publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/42ii.pdf#xml=/cgi-bin/pdf_hl?PAGE=544&DB=semsimple&URL=/pa/cm200405/cmselect/cmhealth/42/42ii.pdf
Refers to: How Well Does the new Medicines and Healthcare products Regulatory Agency (MHRA) Communicate with Your Organisation? Report on a UK-wide email survey of health and social campaigning groups, conducted for the MHRA by PatientView, February 2004, 28 pages.
√ Instituto
Bruno Leoni (IBL) website
Briefing Papers page:
A. Mingardi, C. Stagnaro, 'L'informazione al paziente: problemi
di libertà ed efficienza'
IBL Briefing Paper no. 13, December 15 2004, page 8
Reference to Should Pharmaceutical Companies Provide the Public
with More Information on Prescription Medicines? The Views of EU-Based
Patient Groups,
PatientView, London 2002.
http://brunoleoni.servingfreedom.net/BP/IBL_BP_13_InfoPaziente_Eng.pdf
√ King's
Fund website
Links page: link to PatientView website
March 21 2003
http://www.kingsfund.org.uk/Library/Links.cfm?Let=P
√ University
of Pisa, Centro Interdipartimentale Di Ricerca "E. Piaggio"
Programme to International Workshop: 'NEW GENERATION OF WEARABLE
SYSTEMS FOR E-HEALTH'
Round Table: 'New solutions for personalised health management
citizens' needs and market perspectives'
11-14 December 2003
'The patient's view and ethical considerations of medical technology'Dr
Alexandra Wyke, PatientView, Saturday December 13th 2003.
http://www.piaggio.ccii.unipi.it/~ehealthw/program.htm
Coverage of some of PatientView's projects
What Patients with Cancer
Think of Information on Prescription Medicines
√ Pharma
Marketletter
Survey reveals need for more medicines information to cancer patients
May 26 2003, page 25
"The study, conducted by UK group PatientView, has revealed how
much patients desire more information about their prescription medicines.
A [PatientView] meeting convened to discuss the findings, attended by
patient groups, academia, medical professionals, media and industry
representatives, has concluded that cancer patients know surprisingly
little about the options available for improving their quality and length
of life."
√ The
Pharmaceutical Journal: Briefly
Patients want more information
Vol 270, 24 May 2003, page 713
"A comprehensive policy on the provision of information to cancer
patients is needed, according to the organisation PatientView."
√ Alzheimer
Europe
European Patients' Forum presented at PatientView Meeting in Vienna
March 21 2003
"At a meeting on the information needs of cancer patients organised
by PatientView in Vienna, the Executive Director of Alzheimer Europe
presented the newly-created European Patients' Forum, as well as the
views expressed by a number of EPF members on the pharmaceutical review."
http://www.alzheimer-europe.org/?lm4=10536A65274F
---------------------------------------------------------------------------------------------------------
Should Pharmaceutical Companies
Supply the Public with More Information on Prescription Medicines? The
Views of UK-Based Patient Groups
√
SCRIP:
Daily News Alert
UK patients want more pharma info
November 25, 2002
"Some patient groups would like to see pharmaceutical companies
supplying the public with more information about prescription medicines,
according to a recent survey by PatientView."
---------------------------------------------------------------------------------------------------------
Should Pharmaceutical Companies
Supply the Public with More Information on Prescription Medicines? The
Views of EU-Based Patient Groups
√
Communiqué: Feature
The time is now: confusion over DTC is resulting in missed opportunities
for pharma
Vol 12, July-December 2003, page 53
"Alex Wyke, MD, PatientView, says: ‘Two thirds of patients
feel that they should have the same information as doctors. Patients
feel that access to information is a right, not a concession’."
http://www.pmlive.com/pharm_market.cfm?showArticle=1&ArticleID=2170
√ Picker
Institute Europe website
News: New publications: Recently published books and reports:
WHAT PATIENTS WANTA Summary of the Future Patient Conference:
14-15 November 2002
'The role of pharmaceutical companies in providing information to patients'PatientView,
page 5; Speaker biographiesDr Alexandra Wyke, page 15;
List of participating organisationsPatientView, page 18. http://www.pickereurope.org/news/European_Patient_of_the%20future_what_patients.pdf
√
European Health Forum Gastein
5th EUROPEAN HEALTH FORUM GASTEIN
" Common Challenges for Health and Care"
25-28 September 2002
PatientView and the International Alliance of Patients' Organisations
co-presented a parallel forum, 'Should pharmaceutical companies supply
the public with more information on prescription medicines?'
http://www.ehfg.org/website02/sis.htm
√
Pharmaceutical Marketing
Patients call for good advice
September 2002
"Patients want information about their treatments and they want drug
companies to supply it - albeit with strict controls on medication."
√
The Patients' Network
Letter from the CEO
Summer 2002
"We hope that the publication of the report will ensure that the views
and opinions of many and diverse patients' organizations will be heard
in the debate."
http://www.patientsorganizations.org/tpn/tpn7ena.pdf
√
The Regulatory Affairs
Journal
Prescription medicine information for the public:
a new report
August 2002
"This report provides the opportunity for the views of patients to be
aired on one particular aspect of the legislation - whether direct-to-consumer
information should be provided on prescription medicines by pharmaceutical
companies."
√
Medical Indemnity Register
News
EU patients do not trust doctors and
pharmacists
Summer 2002
"As many as one third of patients in the EU do not always trust their
doctors to give good information on prescription medicines."
√
KHIDI (Korean Health Industry
Development Institute) - Europe
Health Industry News in Europe: Special Report
EU patients do not trust doctors and pharmacists to give satisfactory
information on prescription drugs
June 30, 2002
"A major new survey carried out by independent healthcare consultancy
PatientView, in collaboration with the International Alliance of Patients'
Organizations (IAPO), found that patients in Portugal have the most
faith in their doctors, with 82% highly trusting their doctors to give
reliable information on prescription drugs."
http://www.khidi.or.kr
√
Butterworths Law Direct:
News & features
Patients' right to access information
June 28, 2002
"Plans to relax EU regulations that previously prohibited the promotion
of prescription medicines directly to the public are welcomed by patient
groups."
√
Financial Times:
National News
Patients urge change in law on pharmaceuticals
By Patrick Jenkins - June 18, 2002
"European patients want legislation barring them
from receiving product
information directly from pharmaceuticals companies to be overturned..."
√
BBC News Online
Patients 'don't trust medical advice'
Friday, June 14, 2002, 15:03 GMT 16:03 UK
"Almost half of British patients do not trust their doctor to give
them reliable information on medication."
http://news.bbc.co.uk
√
Pharmafocus: News
story
European DTC war of words declared
Thursday, June 6, 2002
"The war of words over European direct-to-consumer advertising has been
re-ignited as MEPs consider proposals to de-regulate the field."
http://www.pharmafile.com
√ EMEA—the
European Agency for the Evaluation of Medicinal Products
Report from the 1st EMEA/CPMP Workshop with Patients' Organisations:
'Information and Participation'
31May 2002
The EMEA organised a workshop with representatives of seven European
patients' and consumers' organisations. The objectives of this workshop
were to reinforce communication with patients' representatives, to exchange
views on information related to medicinal products and to further explore
contributions to regulatory activities. Keynote results of the PatientView
EU-wide DTCI patient group survey can be found in a six-page pdf at
http://www.emea.eu.int/pdfs/human/patientgroup/presentation14.pdf
---------------------------------------------------------------------------------------------------------
Treatment Options in Primary
Care for Patients with HIV: the Specialist View
√
House of Commons Select
Committee on Health
Third Report: 6. Treatment and Service Provision HIV/AIDS Services
May 22, 2003
"Number 166. The Terrence Higgins Trust and PatientView conduc
ted
a survey which found that GPs were reporting problems collaborating
with specialist HIV services and also understanding the complex issues
around confidentiality and HIV."
http://www.parliament.the-stationery-office.co.uk
(search on PatientView)
√
George House Trust
Insight Briefing 01: ‘HIV Update from George House Trust’
November 2002
"In recent years, two major surveys have been undertaken on the
issue of GP involvement in HIV services. Both surveys were undertaken
by PatientView, a market research and publishing organisation, in partnership
with other agencies, such as the Terrence Higgins Trust." References
on pages 2 and 5 to PatientView's two HIV surveys, 'Managing HIV: a
New Role for GPs' and 'Treatment Options in Primary Care for Patients
with HIV: the Specialist View'.
http://www.ght.org.uk/fileupload/uploads/insightbriefinggp1.pdf
√
House of Commons Hansard
Debates
Sexually Transmitted Infections
May 8, 2002 - 12.58 pm
"The problems highlighted by the survey are worse when considered in
the context of a recent survey
carried out by PatientView, the Terrence Higgins Trust and the British
HIV Association, which asked 100 consultants about the treatment of
patients in GUM clinics."
http://www.parliament.the-stationery-office.co.uk
(search on PatientView)
√
British Medical Journal:
News Extra
Specialists attack government for not prioritising HIV
By Jo Carlowe, 2002; 324: 1416
"A report into the care of patients with HIV infection in the United
Kingdom has shown an upturn in the number of patients, with specialist
clinics stretched to breaking point."
http://bmj.com
back
to top
PatientView, Woodhouse Place, Upper Woodhouse, Knighton, Powys, LD7 1NG, Wales
Tel: 0044-(0)1547-520-965 · E-mail: info@patient-view.com
Registered in England No 3944382
Registered office: Millenium House, 2 Lambeth Hill, London, EC4 4AJ, UK |